PLAUR, Monocyte Activation Antigen Mo3, U-PAR, UPAR, U-Plasminogen Activator Receptor Form 2, CD87 Antigen , CD87, URKR, MO3.
PLAUR produced in Sf9 Baculovirus cells is a single, glycosylated polypeptide chain containing 291 amino acids (23-305 a.a.) and having a molecular mass of 32.5kDa (Molecular size on SDS-PAGE will appear at approximately 40-57 kDa).
PLAUR is fused to a 8 amino acid His-tag at C-terminus & purified by proprietary chromatographic techniques.
PLAUR, Monocyte Activation Antigen Mo3, U-PAR, UPAR, U-Plasminogen Activator Receptor Form 2, CD87 Antigen , CD87, URKR, MO3.
PLAUR is a highly glycosylated protein with a molecular weight of approximately 55-60 kDa. It is anchored to the plasma membrane via a glycosylphosphatidylinositol (GPI) anchor . The primary function of PLAUR is to bind to urokinase plasminogen activator (uPA), facilitating the conversion of plasminogen to plasmin, a serine protease involved in the degradation of the extracellular matrix and fibrinolysis .
PLAUR is significantly implicated in cancer biology. Overexpression of PLAUR and uPA is strongly correlated with poor prognosis in various malignant tumors . The uPA/PLAUR system drives tumor progression by mediating directed extracellular proteolysis on the surface of migrating or invading cells . Targeting PLAUR has been proposed as a novel approach for inhibiting tumor progression, making it a potential therapeutic target in cancer treatment .
Recombinant PLAUR (Human) is produced using DNA sequences encoding the human UPAR isoform 1 (Q03405-1) expressed in HEK293 cells . The recombinant protein is typically tagged with a polyhistidine tag for purification purposes and is used in various research applications, including functional assays and structural studies .
Recombinant PLAUR is widely used in research to study its role in cancer and other diseases. Functional assays, such as ELISA, are employed to measure its binding ability and interactions with other proteins . Additionally, PLAUR’s involvement in the tumor microenvironment and its interaction with tumor-associated macrophages (TAMs) and glioma cells have been subjects of recent studies .